Mechanisms of Osimertinib Resistance in EGFR Mutant Lung Cancer

被引：0
|
作者：
Westover, D. [1 ]
Qiao, H. [1 ]
Ichihara, E. [1 ]
Meador, C. B. [1 ]
Lovly, C. M. [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 08期
关键词：
D O I：
10.1016/j.jtho.2017.06.063
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1546 / S1546
页数：1
相关论文
共 50 条
  • [21] Landscape of EGFR-dependent and independent mechanisms of osimertinib resistance in EGFR-mutant NSCLC patients.
    Le, Xiuning
    Puri, Sonam
    Negrao, Marcelo Vailati
    Nilsson, Monique B.
    Robichaux, Jacqulyne Ponville
    Boyle, Theresa A.
    Hicks, James Kevin
    Roarty, Emily
    Rinsurongkawong, Waree
    Glisson, Bonnie S.
    Zhangx, Jianjun
    Papadimitrakopoulou, Vassiliki
    Gray, Jhanelle Elaine
    Heymach, John
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP)
    Cardona, Andres F.
    Ruiz-Patino, Alejandro
    Recondo, Gonzalo
    Martin, Claudio
    Raez, Luis
    Samtani, Suraj
    Minata, Jose Nicolas
    Blaquier, Juan Bautista
    Enrico, Diego
    Burotto, Mauricio
    Ordonez-Reyes, Camila
    Chamorro, Diego F.
    Garcia-Robledo, Juan Esteban
    Corrales, Luis
    Zatarain-Barron, Zyanya Lucia
    Mas, Luis
    Sotelo, Carolina
    Ricaurte, Luisa
    Santoyo, Nicolas
    Cuello, Mauricio
    Mejia, Sergio
    Jaller, Elvira
    Vargas, Carlos
    Carranza, Hernan
    Otero, Jorge
    Rodriguez, July
    Archila, Pilar
    Bermudez, Maritza
    Gamez, Tatiana
    de Lima, Viadmir Cordeiro
    Freitas, Helano
    Russo, Alessandro
    Polo, Carolina
    Malapelle, Umberto
    Perez, Diego de Miguel
    Rolfo, Christian
    Viola, Lucia
    Rosell, Rafael
    Arrieta, Oscar
    CLINICAL LUNG CANCER, 2022, 23 (06) : 522 - 531
  • [23] Mechanisms of Resistance to First-line Osimertinib in Hispanic Patients with EGFR mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP∫)
    Chamorro, D. F.
    Ruiz-Patino, A.
    Recondo, G.
    Martin, C.
    Raez, L.
    Samtani, S.
    Minata, J. N.
    Blaquier, J. B.
    Enrico, D.
    Burotto, M.
    Ordonez-Reyes, C.
    Garcia-Robledo, J. B.
    Corrales, L.
    Zatarain-Barron, L.
    Mas, L.
    Sotelo, C.
    Ricaurte, L.
    Santoyo, N.
    Cuello, M.
    Mejia, S.
    Jaller, E.
    Vargas, C.
    Carranza, H.
    Otero, J.
    Rodriguez, J.
    Archila, P.
    Bermudez, M.
    Gamez, T.
    de Lima, V. Cordeiro
    Freitas, H.
    Russo, A.
    Polo, C.
    Malapelle, U.
    de Miguel-Perez, D.
    Rolfo, C.
    Viola, L.
    Rossell, R.
    Arrieta, O.
    Cardona, A. F.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S585 - S585
  • [24] Mechanisms of resistance to EGFR inhibitors in lung cancer
    Kobayashi, Yoshihisa
    CANCER SCIENCE, 2025, 116 : 136 - 136
  • [25] Mechanisms of resistance to EGFR inhibitors in lung cancer
    Janne, Pasi
    CANCER RESEARCH, 2016, 76
  • [26] Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancer
    Park, Siyeon
    Park, Seongyeol
    Kim, Tae Min
    Kim, Soyeon
    Koh, Jaemoon
    Lim, Joonoh
    Yi, Kijong
    Yi, Boram
    Ju, Young Seok
    Kim, Miso
    Keam, Bhumsuk
    Kim, Jung Sun
    Jeon, Yoon Kyung
    Kim, Dong-Wan
    Kim, Young Tae
    Heo, Dae Seog
    EUROPEAN JOURNAL OF CANCER, 2024, 208
  • [27] Dysregulated expression of microRNA involved in resistance to osimertinib in EGFR mutant non-small cell lung cancer cells
    Zhang, Dianbao
    Yang, Yukun
    Kang, Yixin
    Xie, Dongjie
    Zhang, Xianfen
    Hao, Jiqing
    JOURNAL OF THORACIC DISEASE, 2023, 15 (04) : 1978 - 1993
  • [28] Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer
    Akiko Takahashi
    Masahiro Seike
    Mika Chiba
    Satoshi Takahashi
    Shinji Nakamichi
    Masaru Matsumoto
    Susumu Takeuchi
    Yuji Minegishi
    Rintaro Noro
    Shinobu Kunugi
    Kaoru Kubota
    Akihiko Gemma
    Scientific Reports, 8
  • [29] Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer
    Takahashi, Akiko
    Seike, Masahiro
    Chiba, Mika
    Takahashi, Satoshi
    Nakamichi, Shinji
    Matsumoto, Masaru
    Takeuchi, Susumu
    Minegishi, Yuji
    Noro, Rintaro
    Kunugi, Shinobu
    Kubota, Kaoru
    Gemma, Akihiko
    SCIENTIFIC REPORTS, 2018, 8
  • [30] Targeting ROR1 in combination with osimertinib in EGFR mutant lung cancer cells
    Nakagawa, Nozomu
    Miyake, Noriko
    Ochi, Nobuaki
    Yamane, Hiromichi
    Takeyama, Masami
    Nagasaki, Yasunari
    Ikeda, Tomoko
    Yokota, Etsuko
    Fukazawa, Takuya
    Nakanishi, Hidekazu
    Harada, Daijiro
    Kiura, Katsuyuki
    Takigawa, Nagio
    EXPERIMENTAL CELL RESEARCH, 2021, 409 (02)
12345